CHWM
ABBV icon

Cauble & Harre Wealth Management’s AbbVie ABBV Stock Holding History

Cauble & Harre Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Buy
1,327
+2
+0.2% +$430 0.27% 58
2026
Q1 		$275K Sell
1,325
-200
-13% -$44.4K 0.22% 64
2025
Q4 		$348K Buy
+1,525
New +$347K 0.29% 54

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cauble & Harre Wealth Management's ABBV Position: Q2 2026 in Review

Cauble & Harre Wealth Management increased its AbbVie (ABBV) stake by 0.15% in Q2 2026, buying an estimated $430 and bringing the position to 1,327 shares worth $334K. The position accounts for 0.27% of the portfolio, ranked #58.

Cauble & Harre Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $348K in Q4 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cauble & Harre Wealth Management held 1,327 shares of AbbVie worth $334K as of Q2 2026.
  • Cauble & Harre Wealth Management bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.27% of Cauble & Harre Wealth Management's portfolio in Q2 2026, its #58 holding.
  • Cauble & Harre Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Cauble & Harre Wealth Management's AbbVie position peaked at $348K in Q4 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cauble & Harre Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.